Berkshire Says Landmark Pitched Compound Scheme as a $1 Million Revenue Stream

Landmark Medical Management allegedly persuaded physicians and chiropractors to participate in a billing scheme with promises of annual payments exceeding $1 million for prescribing compound drugs to injured workers, according to a recently unsealed whistleblower complaint filed by Berkshire Hathaway Homestate Cos.  The complaint filed in the Los Angeles Superior Court on June 26 and unsealed Sept. 16, alleges that Kareem Ahmed, chief executive officer of Landmark, formulated compound drugs based on the profitability of the ingredients and used marketers to solicit doctors to prescribe t...